Brady CorporationNYSE: BRC

Brady Corporation Reports Record Adjusted EPS in its Fiscal 2025 Fourth Quarter and Announces its Fiscal 2026 EPS Guidance

· Issued by Brady Corporation via GlobeNewswire
  • Sales for the quarter increased 15.7 percent. Organic sales increased 2.4 percent, acquisitions increased sales 11.3 percent and foreign currency translation increased sales 2.0 percent.

  • Diluted EPS was $1.04 in the fourth quarter of fiscal 2025 compared to $1.15 in the same quarter of the prior year. Adjusted Diluted EPS* increased 5.9 percent to a record high of $1.26 in the fourth quarter of fiscal 2025 compared to $1.19 in the same quarter of the prior year.

  • Returned $96.4 million to shareholders in fiscal 2025 in the form of dividends and share repurchases.

  • Announced diluted EPS guidance for the year ending July 31, 2026 at a range of $4.55 to $4.85 on a GAAP basis, and a range of $4.85 to $5.15 on an adjusted basis.

MILWAUKEE, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Brady Corporation (NYSE: BRC) (“Brady” or “Company”), a world leader in identification solutions, today reported its financial results for its fiscal 2025 fourth quarter ended July 31, 2025.

Quarter Ended July 31, 2025 Financial Results:
Sales for the quarter ended July 31, 2025 increased 15.7 percent, which consisted of organic sales growth of 2.4 percent, growth of 11.3 percent from acquisitions and an increase of 2.0 percent from foreign currency translation. Sales for the quarter ended July 31, 2025 were $397.3 million compared to $343.4 million in the same quarter last year. By region, sales increased 14.1 percent in the Americas & Asia and sales increased 18.8 percent in Europe & Australia, which consisted of organic sales growth of 4.3 percent in the Americas & Asia and an organic sales decline of 1.3 percent in Europe & Australia.

Income before income taxes was $60.5 million in the quarter ended July 31, 2025, compared to $68.2 million in the same quarter last year. Adjusted Income Before Income Taxes* in the quarter ended July 31, 2025, which was adjusted for amortization expense and facility closure and other reorganization costs of $13.7 million, was $74.2 million, an increase of 5.1 percent compared to the same quarter last year.

Net income for the quarter ended July 31, 2025 was $49.9 million compared to $55.5 million in the same quarter last year. Adjusted Net Income* in the quarter ended July 31, 2025 was $60.2 million compared to $57.3 million in the same quarter last year. Earnings per diluted Class A Nonvoting Common Share was $1.04 compared to $1.15 in the same quarter last year. Adjusted Diluted EPS* in the quarter ended July 31, 2025 was $1.26 compared to $1.19 in the same quarter last year.

Year Ended July 31, 2025 Financial Results:
Sales for the year ended July 31, 2025 increased 12.8 percent, which consisted of organic sales growth of 2.6 percent, growth of 10.5 percent from acquisitions and a decline of 0.3 percent from divestitures. Sales for the year ended July 31, 2025 were $1.51 billion compared to $1.34 billion in the prior year. By region, sales increased 12.1 percent in the Americas & Asia and increased 14.3 percent in Europe & Australia, which consisted of organic sales growth of 4.8 percent in the Americas & Asia and an organic sales decline of 1.8 percent in Europe & Australia.

Income before income taxes was $237.1 million for the year ended July 31, 2025, compared to $247.8 million for the year ended July 31, 2024. Adjusted Income Before Income Taxes* for the year ended July 31, 2025, which was adjusted for amortization expense, facility closure and other reorganization costs and acquisition-related charges of $42.4 million, was $279.5 million, an increase of 8.7 percent.

Net income for the year ended July 31, 2025 was $189.3 million compared to $197.2 million in the prior year. Earnings per diluted Class A Nonvoting Common Share were $3.94 for the year ended July 31, 2025 compared to $4.07 in the prior year. Adjusted Net Income* for the year ended July 31, 2025 was $221.3 million compared to $204.5 million in the prior year, and Adjusted Diluted EPS* for the year ended July 31, 2025 increased to a record-high $4.60 per share compared to $4.22 in the prior year.

Commentary:
“Our investments in new products once again led to strong results in the Americas & Asia region, with 4.3 percent organic sales growth in the fourth quarter and 4.8 percent organic sales growth in fiscal 2025. The result was a new all-time company record quarter and record year of adjusted earnings per share,” said Brady’s President and Chief Executive Officer, Russell R. Shaller. “From an M&A standpoint, we added to our product portfolio this year with the acquisition of Gravotech at the beginning of fiscal 2025, and the acquisition of Mecco, which we closed on August 4, 2025. Both of these companies add direct part marking and laser engraving capabilities to our portfolio of specialty identification products, expanding our ability to provide customers with a wide variety of end-to-end identification solutions to improve visibility and efficiency throughout the manufacturing process.”

“Our balance sheet is strong and we closed the fiscal year in a net cash position, which provides us with the flexibility to fund our anticipated organic and inorganic opportunities, and to return funds to our shareholders through dividends and share buybacks,” said Brady’s Chief Financial Officer, Ann Thornton. “In fiscal 2025, we returned $96.4 million to shareholders through dividends and share buybacks while also investing a record-high in research and development. Through these investments, we believe we are well-positioned to continue to deliver improved long-term value to our shareholders.”

Fiscal 2026 Guidance:
The Company expects GAAP earnings per diluted Class A Nonvoting Common Share to range from $4.55 to $4.85 for the year ending July 31, 2026, which represents an increase of 15.5 percent to 23.1 percent compared to GAAP earnings per diluted Class A Nonvoting Common Share of $3.94 for the year ended July 31, 2025.

The Company expects Adjusted Diluted EPS* to range from $4.85 to $5.15 for the year ending July 31, 2026, which represents an increase of 5.4 percent to 12.0 percent compared to Adjusted Diluted EPS* of $4.60 for the year ended July 31, 2025. Adjusted Diluted EPS* guidance excludes amortization expense estimated at $0.30 per share for the year ending July 31, 2026.

The assumptions included in fiscal 2026 guidance include a full-year income tax rate of approximately 21 percent, depreciation and amortization expense of approximately $42 million, and capital expenditures of approximately $40 million. Fiscal 2026 guidance is based upon foreign currency exchange rates as of July 31, 2025 and assumes economic growth.

A webcast regarding Brady’s fiscal 2025 fourth quarter financial results will be available at www.bradycorp.com/investors beginning at 9:30 a.m. central time today.

Brady Corporation is an international manufacturer and marketer of complete solutions that identify and protect people, products and places. Brady’s products help customers increase safety, security, productivity and performance and include high-performance labels, signs, safety devices, printing systems and software. Founded in 1914, the Company has a diverse customer base in electronics, telecommunications, manufacturing, electrical, construction, medical, aerospace and a variety of other industries. Brady is headquartered in Milwaukee, Wisconsin and as of July 31, 2025, employed approximately 6,400 people in its worldwide businesses. Brady’s fiscal 2025 sales were approximately $1.51 billion. Brady stock trades on the New York Stock Exchange under the symbol BRC. More information is available on the Internet at www.bradyid.com.

* Adjusted Income Before Income Taxes, Adjusted Net Income, and Adjusted Diluted EPS are non-GAAP measures. See appendix for more information on these measures, including reconciliations to the most directly comparable GAAP measures.

In this news release, statements that are not reported financial results or other historic information are “forward-looking statements.” These forward-looking statements relate to, among other things, the Company's future financial position, business strategy, targets, projected sales, costs, earnings, capital expenditures, debt levels and cash flows, and plans and objectives of management for future operations.

The use of words such as “may,” “will,” “expect,” “intend,” “estimate,” “anticipate,” “believe,” “should,” “project,” “plan” or similar terminology are generally intended to identify forward-looking statements. These forward-looking statements by their nature address matters that are, to different degrees, uncertain and are subject to risks, assumptions, and other factors, some of which are beyond Brady’s control, that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. For Brady, uncertainties arise from: increased cost of materials, labor, material shortages and supply chain disruptions, including as a result of tariffs or other impacts of the global trade environment; decreased demand for our products; our ability to compete effectively or to successfully execute our strategy; our ability to develop technologically advanced products that meet customer demands; Brady’s ability to identify, integrate and grow acquired companies, and to manage contingent liabilities from divested businesses; difficulties in protecting our websites, networks, and systems against security breaches; extensive regulations by U.S. and non-U.S. governmental and self-regulatory entities; risks associated with the loss of key employees; litigation, including product liability claims; global climate change and environmental regulations; foreign currency fluctuations; changes in tax legislation and tax rates; potential write-offs of goodwill and other intangible assets; differing interests of voting and non-voting shareholders and changes in the regulatory and business environment around dual-class voting structures; numerous other matters of national, regional and global scale, including major public health crises and government responses thereto and those of a political, economic, business, competitive, and regulatory nature contained from time to time in Brady’s U.S. Securities and Exchange Commission filings, including, but not limited to, those factors listed in the “Risk Factors” section within Item 1A of Part I of Brady’s Form 10-K for the year ended July 31, 2025.

These uncertainties may cause Brady's actual future results to be materially different than those expressed in its forward-looking statements. Brady does not undertake to update its forward-looking statements except as required by law.

For More Information:
Investor contact: Ann Thornton 414-438-6887
Media contact: Kate Venne 414-358-5176

BRADY CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF INCOME

(Unaudited; Dollars in thousands, except per share data)

Three months ended July 31,

Year ended July 31,

2025

2024

2025

2024

Net sales

$

397,275

$

343,402

$

1,513,605

$

1,341,393

Cost of goods sold

197,044

166,347

752,783

653,509

Gross margin

200,231

177,055

760,822

687,884

Operating expenses:

Research and development

23,054

17,533

79,889

67,748

Selling, general and administrative

117,885

93,307

444,295

376,722

Total operating expenses

140,939

110,840

524,184

444,470

Operating income

59,292

66,215

236,638

243,414

Other income (expense):

Investment and other income

2,356

2,835

5,206

7,553

Interest expense

(1,143

)

(842

)

(4,747

)

(3,126

)

Income before income taxes

60,505

68,208

237,097

247,841

Income tax expense

10,629

12,752

47,841

50,626

Net income

$

49,876

$

55,456

$

189,256

$

197,215

Net income per Class A Nonvoting Common Share:

Basic

$

1.05

$

1.17

$

3.97

$

4.10

Diluted

$

1.04

$

1.15

$

3.94

$

4.07

Net income per Class B Voting Common Share:

Basic

$

1.05

$

1.17

$

3.96

$

4.08

Diluted

$

1.04

$

1.15

$

3.92

$

4.05

Weighted average common shares outstanding:

Basic

47,335

47,595

47,641

48,119

Diluted

47,780

48,063

48,092

48,496

BRADY CORPORATION AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(Dollars in thousands)

July 31, 2025

July 31, 2024

ASSETS

Current assets:

Cash and cash equivalents

$

174,349

$

250,118

Accounts receivable, net of allowance for credit losses of $7,876 and $6,749, respectively

231,944

185,486

Inventories

200,881

152,729

Prepaid expenses and other current assets

14,661

11,382

Total current assets

621,835

599,715

Property, plant and equipment—net

225,572

195,758

Goodwill

676,945

589,611

Other intangible assets

105,374

51,839

Deferred income taxes

20,862

15,596

Operating lease assets

58,422

38,504

Other assets

25,243

24,546

Total

$

1,734,253

$

1,515,569

LIABILITIES AND STOCKHOLDERS’ EQUITY

Current liabilities:

Accounts payable

$

105,028

$

84,691

Accrued compensation and benefits

92,657

77,954

Taxes, other than income taxes

21,537

14,061

Accrued income taxes

5,547

7,424

Current operating lease liabilities

15,234

13,382

Other current liabilities

90,329

67,170

Total current liabilities

330,332

264,682

Long-term debt

99,766

90,935

Long-term operating lease liabilities

43,565

25,342

Other liabilities

68,379

67,952

Total liabilities

542,042

448,911

Stockholders’ equity:

Common stock:

Class A nonvoting common stock—Issued 51,261,487 shares, and outstanding 43,530,012 and 44,042,462 shares, respectively

513

513

Class B voting common stock—Issued and outstanding, 3,538,628 shares

35

35

Additional paid-in capital

359,269

353,654

Retained earnings

1,317,739

1,174,025

Treasury stock—7,731,475 and 7,219,025 shares, respectively, of Class A nonvoting common stock, at cost

(393,186

)

(351,947

)

Accumulated other comprehensive loss

(92,159

)

(109,622

)

Total stockholders’ equity

1,192,211

1,066,658

Total

$

1,734,253

$

1,515,569

BRADY CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited; Dollars in thousands)

Year ended July 31,

2025

2024

Operating activities:

Net income

$

189,256

$

197,215

Adjustments to reconcile net income to net cash provided by operating activities:

Depreciation and amortization

40,639

29,873

Stock-based compensation expense

11,882

7,361

Deferred income taxes

(7,623

)

(9,399

)

Other

(2,540

)

1,401

Changes in operating assets and liabilities:

Accounts receivable

(14,356

)

(6,581

)

Inventories

(18,889

)

21,697

Prepaid expenses and other assets

(2,098

)

(743

)

Accounts payable and accrued liabilities

(9,862

)

19,198

Income taxes

(5,213

)

(4,948

)

Net cash provided by operating activities

181,196

255,074

Investing activities:

Purchases of property, plant and equipment

(27,577

)

(79,892

)

Acquisition of businesses, net of cash acquired

(144,541

)

—

Other

864

(1,155

)

Net cash used in investing activities

(171,254

)

(81,047

)

Financing activities:

Payment of dividends

(45,542

)

(45,060

)

Proceeds from exercise of stock options

6,171

8,186

Payments for employee taxes withheld from stock-based awards

(2,683

)

(2,797

)

Purchase of treasury stock

(50,838

)

(72,225

)

Proceeds from borrowing on credit agreement

266,846

175,103

Repayment of borrowing on credit agreement

(258,015

)

(133,884

)

Other

190

149

Net cash used in financing activities

(83,871

)

(70,528

)

Effect of exchange rate changes on cash and cash equivalents

(1,840

)

(4,913

)

Net (decrease) increase in cash and cash equivalents

(75,769

)

98,586

Cash and cash equivalents, beginning of period

250,118

151,532

Cash and cash equivalents, end of period

$

174,349

$

250,118

BRADY CORPORATION AND SUBSIDIARIES

SEGMENT INFORMATION

(Unaudited; Dollars in thousands)

Three months ended July 31,

Year ended July 31,

2025

2024

2025

2024

NET SALES

Americas & Asia

$

260,789

$

228,493

$

993,715

$

886,528

Europe & Australia

136,486

114,909

519,890

454,865

Total

$

397,275

$

343,402

$

1,513,605

$

1,341,393

SALES INFORMATION

Americas & Asia

Organic

4.3

%

3.4

%

4.8

%

3.1

%

Acquistions

9.8

%

—

%

8.3

%

—

%

Currency

—

%

(0.8

)%

(0.6

)%

(0.2

)%

Divestiture

—

%

(2.2

)%

(0.4

)%

(3.2

)%

Total

14.1

%

0.4

%

12.1

%

(0.3

)%

Europe & Australia

Organic

(1.3

)%

(1.8

)%

(1.8

)%

1.6

%

Acquistions

14.4

%

—

%

14.7

%

—

%

Currency

5.7

%

(1.2

)%

1.4

%

1.1

%

Total

18.8

%

(3.0

)%

14.3

%

2.7

%

Total Company

Organic

2.4

%

1.6

%

2.6

%

2.6

%

Acquistions

11.3

%

—

%

10.5

%

—

%

Currency

2.0

%

(0.8

)%

—

%

0.2

%

Divestiture

—

%

(1.5

)%

(0.3

)%

(2.1

)%

Total

15.7

%

(0.7

)%

12.8

%

0.7

%

SEGMENT PROFIT

Americas & Asia

$

51,617

$

53,353

$

209,765

$

196,842

Europe & Australia

15,070

19,277

56,942

70,612

Total segment profit

$

66,687

$

72,630

$

266,707

$

267,454

SEGMENT PROFIT AS A PERCENT OF NET SALES

Americas & Asia

19.8

%

23.3

%

21.1

%

22.2

%

Europe & Australia

11.0

%

16.8

%

11.0

%

15.5

%

Total

16.8

%

21.2

%

17.6

%

19.9

%

Three months ended July 31,

Year ended July 31,

2025

2024

2025

2024

Total segment profit

$

66,687

$

72,630

$

266,707

$

267,454

Unallocated amounts:

Administrative costs

(7,395

)

(6,415

)

(30,069

)

(24,040

)

Investment and other income

2,356

2,835

5,206

7,553

Interest expense

(1,143

)

(842

)

(4,747

)

(3,126

)

Income before income taxes

$

60,505

$

68,208

$

237,097

$

247,841

GAAP to NON-GAAP MEASURES

(Unaudited; Dollars in Thousands, Except Per Share Amounts)

In accordance with the U.S. Securities and Exchange Commission’s Regulation G, the following provides definitions of the non-GAAP measures used in the earnings release and the reconciliation to the most closely related GAAP measure.

Adjusted Income Before Income Taxes:

Brady is presenting the non-GAAP measure, "Adjusted Income Before Income Taxes." This is not a calculation based upon GAAP. The amounts included in this non-GAAP measure are derived from amounts included in the Consolidated Financial Statements and supporting footnote disclosures. We do not view these items to be part of our ongoing results. We believe this profit measure provides an important perspective of underlying business trends and results and provides a more comparable measure from year to year. The table below provides a reconciliation of the GAAP measure of Income before income taxes to the non-GAAP measure of Adjusted Income Before Income Taxes:

Three months ended July 31,

Year ended July 31,

2025

2024

2025

2024

Income before income taxes (GAAP measure)

$

60,505

$

68,208

$

237,097

$

247,841

Amortization expense

4,778

2,337

18,916

9,421

Facility closure and other reorganization costs

8,890

-

18,474

-

Non-recurring acquisitions-related costs and other expenses

-

-

5,059

-

Adjusted Income Before Income Taxes (non-GAAP measure)

$

74,173

$

70,545

$

279,546

$

257,262

Adjusted Income Tax Expense:

Brady is presenting the non-GAAP measure, "Adjusted Income Tax Expense." This is not a calculation based upon GAAP. The amounts included in this non-GAAP measure are derived from amounts included in the Consolidated Financial Statements and supporting footnote disclosures. We do not view these items to be part of our ongoing results. We believe this measure provides an important perspective of underlying business trends and results and provides a more comparable measure from year to year. The table below provides a reconciliation of the GAAP measure of Income tax expense to the non-GAAP measure of Adjusted Income Tax Expense:

Three months ended July 31,

Year ended July 31,

2025

2024

2025

2024

Income tax expense (GAAP measure)

$

10,629

$

12,752

$

47,841

$

50,626

Amortization expense

1,148

540

4,550

2,182

Facility closure and other reorganization costs

2,222

-

4,618

-

Non-recurring acquisitions-related costs and other expenses

-

-

1,265

-

Adjusted Income Tax Expense (non-GAAP measure)

$

13,999

$

13,292

$

58,274

$

52,808

Adjusted Net Income:

Brady is presenting the non-GAAP measure, "Adjusted Net Income." This is not a calculation based upon GAAP. The amounts included in this non-GAAP measure are derived from amounts included in the Consolidated Financial Statements and supporting footnote disclosures. We do not view these items to be part of our ongoing results. We believe this measure provides an important perspective of underlying business trends and results and provides a more comparable measure from year to year. The table below provides a reconciliation of the GAAP measure of Net income to the non-GAAP measure of Adjusted Net Income:

Three months ended July 31,

Year ended July 31,

2025

2024

2025

2024

Net income (GAAP measure)

$

49,876

$

55,456

$

189,256

$

197,215

Amortization expense

3,630

1,797

14,366

7,239

Facility closure and other reorganization costs

6,668

-

13,856

-

Non-recurring acquisitions-related costs and other expenses

-

-

3,794

-

Adjusted Net Income (non-GAAP measure)

$

60,174

$

57,253

$

221,272

$

204,454

Adjusted Diluted EPS:

Brady is presenting the non-GAAP measure, "Adjusted Diluted EPS." This is not a calculation based upon GAAP. The amounts included in this non-GAAP measure are derived from amounts included in the Consolidated Financial Statements. We do not view these items to be part of our ongoing results. We believe this measure provides an important perspective of underlying business trends and results and provides a more comparable measure from year to year. The table below provides a reconciliation of the GAAP measure of Net income per Class A Nonvoting Common Share to the non-GAAP measure of Adjusted Diluted EPS (Note that certain amounts will not foot due to rounding):

Three months ended July 31,

Year ended July 31,

2025

2024

2025

2024

Net income per Class A Nonvoting Common Share (GAAP measure)

$

1.04

$

1.15

$

3.94

$

4.07

Amortization expense

0.08

0.04

0.30

0.15

Facility closure and other reorganization costs

0.14

-

0.29

-

Non-recurring acquisitions-related costs and other expenses

-

-

0.08

-

Adjusted Diluted EPS (non-GAAP measure)

$

1.26

$

1.19

$

4.60

$

4.22

Adjusted Diluted EPS Guidance:

Fiscal 2026 Expectations

Low

High

Earnings per diluted Class A Common Share (GAAP measure)

$

4.55

$

4.85

Amortization expense

0.30

0.30

Adjusted Diluted EPS (non-GAAP measure)

$

4.85

$

5.15

Company analysis